Athena regulatory update

ATHN's U.K. subsidiary, Athena Neurosciences (Europe) Ltd., submitted a PLA for U.K. approval of Zanaflex (tizanidine hydrochloride), an alpha-2-adrenergic agonist, to treat spasticity associated wit...